|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/15/22 International Isotopes Inc. 10-Q 6/30/22 57:4.8M EDGARSources LLC/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 978K
2: EX-31 Certification -- §302 - SOA'02 -- exhibit311 HTML 19K
3: EX-31 Certification -- §302 - SOA'02 -- exhibit312 HTML 19K
4: EX-32 Certification -- §906 - SOA'02 -- exhibit321 HTML 17K
5: EX-32 Certification -- §906 - SOA'02 -- exhibit322 HTML 17K
11: R1 Cover HTML 64K
12: R2 Consolidated Balance Sheets (Unaudited) HTML 157K
13: R3 Consolidated Balance Sheets (Unaudited) HTML 26K
(Parenthetical)
14: R4 Condensed Consolidated Statements of Operations HTML 104K
(Unaudited)
15: R5 Condensed Consolidated Statements of Cash Flows HTML 110K
(Unaudited)
16: R6 Reconciliatoin of Stockholders' (Deficit) Equity HTML 100K
(Unaudited)
17: R7 The Company and Basis of Presentation HTML 28K
18: R8 Current Developments and Liquidity HTML 23K
19: R9 Net Income (Loss) Per Common Share - Basic and HTML 48K
Diluted
20: R10 RadQual Acquisition HTML 22K
21: R11 Inventories HTML 29K
22: R12 Stockholders? Equity, Options, and Warrants HTML 88K
23: R13 Debt HTML 46K
24: R14 Commitments and Contingencies HTML 26K
25: R15 Revenue Recognition HTML 87K
26: R16 Leases HTML 48K
27: R17 Segment Information HTML 120K
28: R18 The Company and Basis of Presentation (Policies) HTML 27K
29: R19 Net Income (Loss) Per Common Share - Basic and HTML 40K
Diluted (Tables)
30: R20 Inventories (Tables) HTML 26K
31: R21 Stockholders? Equity, Options, and Warrants HTML 35K
(Tables)
32: R22 Revenue Recognition (Tables) HTML 80K
33: R23 Leases (Tables) HTML 48K
34: R24 Segment Information (Tables) HTML 115K
35: R25 The Company and Basis of Presentation (Details HTML 20K
Narrative)
36: R26 Current Developments and Liquidity (Details HTML 32K
Narrative)
37: R27 Net Income (Loss) Per Common Share - Schedule of HTML 25K
Weighted Average Number of Shares (Details)
38: R28 Net Income (Loss) Per Common Share - Basic and HTML 35K
Diluted - Schedule of Common Stock Equivalents
Outstanding (Details)
39: R29 Net Income (Loss) Per Common Share - Basic and HTML 30K
Diluted (Details Narrative)
40: R30 RadQual Acquisition (Details Narrative) HTML 24K
41: R31 Inventories - Schedule of Inventory, Current HTML 23K
(Details)
42: R32 Inventories (Details Narrative) HTML 25K
43: R33 Stockholders? Equity, Options and Warrants - HTML 57K
Schedule of Share-Based Compensation Stock Option
Activity (Details)
44: R34 Stockholders? Equity, Options, and Warrants HTML 189K
(Details Narrative)
45: R35 Debt (Details Narrative) HTML 73K
46: R36 Commitments and Contingencies (Details Narrative) HTML 23K
47: R37 Revenue Recognition - Summary of Sales from HTML 50K
Contracts with Customers Disaggregated by Business
Segment and Geography (Details)
48: R38 Revenue Recognition (Details Narrative) HTML 23K
49: R39 Leases - Schedule of Lease Expense (Details) HTML 47K
50: R40 Leases - Schedule of Future Minimum Payments of HTML 65K
Lease Liabilities (Details)
51: R41 Segment Information - Schedule of Segment HTML 81K
Reporting Information by Segment (Details)
52: R42 Segment Information (Details Narrative) HTML 19K
55: XML IDEA XML File -- Filing Summary XML 98K
53: XML XBRL Instance -- inis10q063022_htm XML 1.27M
54: EXCEL IDEA Workbook of Financial Reports XLSX 94K
7: EX-101.CAL XBRL Calculations -- inis-20220630_cal XML 135K
8: EX-101.DEF XBRL Definitions -- inis-20220630_def XML 298K
9: EX-101.LAB XBRL Labels -- inis-20220630_lab XML 769K
10: EX-101.PRE XBRL Presentations -- inis-20220630_pre XML 568K
6: EX-101.SCH XBRL Schema -- inis-20220630 XSD 96K
56: JSON XBRL Instance as JSON Data -- MetaLinks 299± 422K
57: ZIP XBRL Zipped Folder -- 0001515971-22-000152-xbrl Zip 198K
| Exhibit 32.2 |
Exhibit 32.2
CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of International Isotopes Inc. and subsidiaries (the “Company”) for the period ended June 30, 2022, as filed with the Securities and Exchange Commission (the “Form 10-Q”), I, W. Matthew Cox, Chief Financial Officer of the Company, in my capacity as such, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
| (1) | The Form 10-Q fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended (15 U.S.C. 78m or 78o(d)); and |
| (2) | The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| August 15, 2022 | /s/ W. Matthew Cox |
| W. Matthew Cox | |
| Chief Financial Officer |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 8/15/22 | None on these Dates | ||
| For Period end: | 6/30/22 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/22/22 International Isotopes Inc. 8-K:2,3,5,9 2/16/22 11:191K EDGARSources LLC/FA 2/24/17 International Isotopes Inc. 8-K:1,3,5,9 2/17/17 4:218K EDGARSources LLC/FA 8/16/10 International Isotopes Inc. 10-Q 6/30/10 7:83M Barker Darrell/FA 5/01/97 International Isotopes Inc. SB-2 10:572K CT EDGAR123/FA |